US EditionAvant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology
Summary by ocolly.com
7 Articles
7 Articles
All
Left
2
Center
2
Right
Cleburne Times-Review+5 Reposted by 5 other sources
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology
LAS VEGAS, NEVADA / ACCESS Newswire / April 29, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial…
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology - Financial News Media
Las Vegas, NV - April 29, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that T
Coverage Details
Total News Sources7
Leaning Left2Leaning Right0Center2Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
